Company Orient EuroPharma Co., Ltd.

4120

TW0004120001

Food Processing

End-of-day quote Taipei Exchange Other stock markets 2026-05-20			5-day change	1st Jan Change
46.30 ^TWD	+0.22%		-0.43%	+3.35%

May. 13	Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 01	Kissei Pharmaceutical Co Ltd - licensing agreement for "Olutasidenib" with Orient EuroPharma in Taiwan	RE

Business description: Orient EuroPharma Co., Ltd.

Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.

Sales by Activity: Orient EuroPharma Co., Ltd.

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Western Medicine Segment	2.23B	2.33B	2.43B	2.74B	2.91B
Nutrition and Health Sector	2.54B	2.4B	2.17B	1.65B	1.69B

See all business segments

Geographical breakdown of sales: Orient EuroPharma Co., Ltd.

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Taiwan	2.7B	2.79B	2.88B	3.08B	3.22B
Southeast Asia	845M	910M	993M	1.06B	1.21B
China	1.23B	1.04B	702M	242M	159M
Other	-	-	12.74M	1.98M	2.03M

See all geographic segments

Executive Committee: Orient EuroPharma Co., Ltd.

Manager	Title	Age	Since
Mon Lin Tsai CEO	Chief Executive Officer	-	2022-06-29
Phoebe Lee DFI	Director of Finance/CFO	-	1996-05-14
Sandy Kuo ADM	Chief Administrative Officer	-	2020-08-31
Anita Chen IRC	Investor Relations Contact	-	-
PC Yang PRN	Corporate Officer/Principal	-	2023-03-31

See ORIENT EUROPHARMA CO., LTD. governance

Composition of the Board of Directors: Orient EuroPharma Co., Ltd.

Director	Title	Age	Since
Praveen Tyle BRD	Director/Board Member	66	2010-03-15
Cheng Hung Tsai CHM	Chairman	-	2010-03-15
Chin Hsin Hsu BRD	Director/Board Member	-	2016-06-02
Shui Yung Lin BRD	Director/Board Member	-	-
Mon Lin Tsai BRD	Director/Board Member	-	2022-06-29
Chih-Chen Chou BRD	Director/Board Member	-	-

Composition of the Board of Directors

Company details: Orient EuroPharma Co., Ltd.

Orient Europharma Co. Ltd.

13th Floor, No. 128

112, Taipei

http://www.oep.com.tw

address Orient EuroPharma Co., Ltd.(4120)

Special Foods & Wellbeing Products

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ORIENT EUROPHARMA CO., LTD.	+0.22%	-0.43%	-4.14%	+20.26%	126M
ZHEJIANG NHU COMPANY LTD.	-1.33%	-6.84%	+36.83%	+89.61%	14.26B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-1.27%	-10.00%	-29.88%	+155.77%	6.11B
BYHEALTH CO., LTD	-1.08%	-4.83%	-11.15%	-55.69%	2.5B
TSI GROUP CO., LTD.	+2.81%	+7.20%	-	-	1.59B
XIAMEN KINGDOMWAY GROUP COMPANY	-0.98%	+1.70%	-13.81%	-18.50%	1.46B
HERBALIFE LTD.	+3.37%	-7.78%	+81.39%	-5.98%	1.26B
JAMIESON WELLNESS INC.	+1.22%	+0.93%	+0.49%	+8.87%	1.03B
BELLRING BRANDS, INC.	+0.90%	-5.38%	-86.55%	-74.70%	1.03B
THE SIMPLY GOOD FOODS COMPANY	-2.02%	-1.41%	-69.03%	-70.36%	1.03B
Average	+0.28%	-2.73%	-10.65%	+5.47%	3.04B
Weighted average by Cap.	-0.69%	-4.27%	+8.20%	+66.56%